The U.S. government will pay vaccine maker Moderna $176 million dollars to accelerate development of a vaccine that could be used to prevent bird flu in people. The new funds are for continued development, including a late-stage trial next year if those early study results are positive. Katherine Ward has this story and more in Health Matters for July 3, 2024.
Health Matters
Health Matters: U.S. to pay Moderna $176M to develop bird flu vaccine
More Videos
-
Health Matters: New regulations targeting illegal drug chemicals, equipment
-
Health Matters: Eli Lilly says new oral pill helps maintain weight loss
-
Flu cases surge across Canada with H3N2 as the dominant strain of the virus
-
Health Matters: Flu season spiking ahead of holiday season, experts say
-
Health Matters: COVID-19 vaccine can offer protection in pregnancy, new study finds
-
Health Matters: Alberta government invokes notwithstanding clause for 4th time
You are viewing an Accelerated Mobile Webpage.
View Original Article